UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Larimar Therapeutics
LRMR
$432M
| $1.22M | ﹤0.01% |
+2,569
| New | +$1.22M |
|
1502
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $1.22M | ﹤0.01% |
127,766
+55,315
| +76% | +$497K |
|
|
PDS
1503
Precision Drilling
PDS
$974M
| $1.22M | ﹤0.01% |
9,576
+2,791
| +41% | +$320K |
|
|
MPT
1504
Medical Properties Trust
MPT
$2.81B
| $1.22M | ﹤0.01% |
82,395
+26,700
| +48% | +$397K |
|
1505
MarketAxess Holdings
MKTX
$5.72B
| $1.21M | ﹤0.01% |
14,599
+700
| +5% | +$55.4K |
|
|
PHH
1506
DELISTED
PHH Corporation
PHH
| $1.21M | ﹤0.01% |
49,971
+8,780
| +21% | +$212K |
|
1507
Lithia Motors
LAD
$8.26B
| $1.2M | ﹤0.01% |
12,099
+400
| +3% | +$35.9K |
|
|
PVTB
1508
DELISTED
PrivateBancorp Inc
PVTB
| $1.2M | ﹤0.01% |
34,198
+1,500
| +5% | +$50.7K |
|
|
ABMD
1509
DELISTED
Abiomed Inc
ABMD
| $1.2M | ﹤0.01% |
16,799
+1,600
| +11% | +$86.8K |
|
1510
PRA Group
PRAA
$755M
| $1.2M | ﹤0.01% |
22,100
+900
| +4% | +$48.1K |
|
1511
Archrock
AROC
$5.8B
| $1.19M | ﹤0.01% |
35,498
+1,200
| +3% | +$36.6K |
|
|
BID
1512
DELISTED
Sotheby's
BID
| $1.19M | ﹤0.01% |
28,098
+1,200
| +4% | +$51.2K |
|
|
CVSA
1513
Covista Inc
CVSA
$4.8B
| $1.18M | ﹤0.01% |
35,430
+2,100
| +6% | +$81.5K |
|
|
AAV
1514
DELISTED
Advantage Oil & Gas Ltd
AAV
| $1.18M | ﹤0.01% |
219,440
+3,300
| +2% | +$16K |
|
1515
Crocs
CROX
$6.55B
| $1.18M | ﹤0.01% |
99,961
-56,559
| -36% | -$634K |
|
|
PPO
1516
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $1.18M | ﹤0.01% |
19,998
+3,700
| +23% | +$191K |
|
1517
Helen of Troy
HELE
$693M
| $1.17M | ﹤0.01% |
14,399
+400
| +3% | +$30.5K |
|
|
DF
1518
DELISTED
Dean Foods Company
DF
| $1.17M | ﹤0.01% |
70,785
-45,488
| -39% | -$781K |
|
1519
Valley National Bancorp
VLY
$8.04B
| $1.16M | ﹤0.01% |
123,133
+8,000
| +7% | +$75.7K |
|
|
FUR
1520
DELISTED
WINTHROP REALTY TRUST SHS BENE INT (NEW)
FUR
| $1.16M | ﹤0.01% |
71,273
+1,600
| +2% | +$25.7K |
|
|
RSE
1521
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.16M | ﹤0.01% |
61,214
+900
| +1% | +$16.8K |
|
|
ANAC
1522
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $1.16M | ﹤0.01% |
20,000
+8,500
| +74% | +$361K |
|
1523
Precigen
PGEN
$2.59B
| $1.15M | ﹤0.01% |
26,472
+1,779
| +7% | +$63.9K |
|
1524
ACI Worldwide
ACIW
$5.42B
| $1.14M | ﹤0.01% |
52,797
+2,300
| +5% | +$45.7K |
|
|
CEB
1525
DELISTED
CEB Inc.
CEB
| $1.14M | ﹤0.01% |
14,308
+500
| +4% | +$37.6K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.